Skip to main content
An official website of the United States government
Email

Past Childhood Cancer Data Initiative Webinars

Childhood Cancer Data Initiative (CCDI) webinars communicate the initiative’s goals and activities, highlight progress, and demonstrate how to find and use CCDI web applications, platforms, and data.

If you missed a webinar, access past recordings and presentations below.

2025 | 2024 | 2023

White text in the middle of the image that reads, "Scientific Presentation," overlaid onto a blue background showing an icon of a computer and six people on the screen

May 13, 2025: Pre-clinical Evaluation of Targeted Therapies for Pediatric Cancer

This webinar explores Pediatric Preclinical in Vivo Testing (PIVOT), an NCI-funded program evaluating targeted cancer therapies developed for adult oncology to determine if they have relevance to childhood cancers. Topics covered include mission and history, lessons learned, past and recent multi-modal omics characterization of human-in-mouse tumors, and how to access relevant genomic and efficacy study data.

Access the event presentation and event recording. 

 

White text in the middle of the image that reads, "Demo," overlaid onto a blue background showing an icon of a computer and six people on the screen

January 14, 2025: Unlock the Power of Unstructured Data with EMERSE

This webinar introduces EMERSE, a text processing system designed specifically for non-technical users. It shows how the system can help you efficiently work with free text (unstructured data) from electronic health record systems.

Access the event presentation and event recording.

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Past Childhood Cancer Data Initiative Webinars was originally published by the National Cancer Institute.”

Email